| NCT ID | NCT03851484 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vanderbilt University Medical Center |
| Condition | Tourette Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 214 participants |
| Start Date | 2019-04-17 |
| Primary Completion | 2028-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 214 participants in total. It began in 2019-04-17 with a primary completion date of 2028-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with tics will be asked to complete a series of validated questionnaires (in electronic and/or paper format) regarding symptoms and conditions often associated with Tourette syndrome, including premonitory urges, sensory experiences, inattention, obsessive-compulsive tendencies, anxiety, and depression. Participants will also be asked to complete a quality of life assessment. This series of questionnaires will be administered annually.
Eligibility Criteria
Inclusion criteria: * 18 years of age or older * Ability to provide informed consent and answer self-report questionnaires independently in English * Diagnosis of Tourette syndrome (TS), chronic motor tic disorder, or chronic vocal tic disorder Exclusion criteria: * History of psychotic disorder * History of significant neurologic disorder (e.g., stroke) other than TS or another chronic tic disorder
Contact & Investigator
David A Isaacs, MD, MPH
PRINCIPAL INVESTIGATOR
Vanderbilt University Medical Center
Frequently Asked Questions
Who can join the NCT03851484 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tourette Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03851484 currently recruiting?
Yes, NCT03851484 is actively recruiting participants. Contact the research team at michelle.r.eckland.1@vumc.org for enrollment information.
Where is the NCT03851484 trial being conducted?
This trial is being conducted at Nashville, United States, Nashville, United States.
Who is sponsoring the NCT03851484 clinical trial?
NCT03851484 is sponsored by Vanderbilt University Medical Center. The principal investigator is David A Isaacs, MD, MPH at Vanderbilt University Medical Center. The trial plans to enroll 214 participants.